ALTRESYN DIN 02454882
Health Canada record
| Active ingredient(s) | ALTRENOGEST 2.2 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 25-Apr-2017 |
| Current status date | 27-Jun-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ceva Animal Health Inc — licence 102054, currently licensed, last inspection rating C (2024-07-31).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALTRENOGEST
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02464047 | ALTERMATE | ARIVAC INC. | Solution | ALTRENOGEST 2.2 MG | Approved |
| 02519135 | ALTREN SOLUTION 0.22% | AURORA PHARMACEUTICAL, INC. | Solution | ALTRENOGEST 2.2 MG | Marketed |
| 00641987 | REGU-MATE SOLUTION 0.22% | INTERVET CANADA CORP | Solution | ALTRENOGEST 2.2 MG | Marketed |
| 00870919 | REGU-MATE GEL 2.15MG/G | INTERVET CANADA CORP | Gel | ALTRENOGEST 2.15 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 18109 | 2016-05-18 | Abbreviated New Drug Submission (ANDS) |
International API supply for ALTRENOGEST
1 active FDA Drug Master Files.
Request a quote for ALTRESYN